Literature DB >> 33860990

Trends and causes of readmission following peripheral vascular intervention in patients with peripheral vascular disease.

Homam Moussa Pacha1, Tanveer Mir2, Yasser Al-Khadra3, Yasar Sattar4, Waqas Ullah5, Nathan Zaher6, Bachar Ahmad2, Abdul-Rahman M Suleiman2, Fahed Darmoch6, Mohamad Soud7, Haroon Faraz8, Zaher Hakim2, M Chadi Alraies2.   

Abstract

OBJECTIVES: To study the risk factors associated with 30-readmission postperipheral vascular intervention (PVI) in peripheral artery disease (PAD).
BACKGROUND: There has been a paucity of data regarding the trend and predictors of PVI readmission.
METHODS: We performed an observational cohort study of patients admitted with peripheral vascular disease for PVI using the NRD for the years 2010-2014. PVI was defined as angioplasty, atherectomy, and/or stenting of lower limb vessels.
RESULTS: A total of 453,278 patients (30-day readmission n = 97,235). The mean age of study population was 68.6 ± 12.2 years and included 43.8% women. The 30-day readmission post-PVI (p = .034). Cardiovascular causes constitute 44% of readmission. Chronic limb ischemia and intermittent claudication were two most common cardiovascular causes constituting 11.7 and 4.9% cases of readmissions. Other cardiac causes of readmissions included heart failure (4.64%), dysrhythmias (1.4%), and acute myocardial infarction (1.7%). The high-risk factors for of all-cause 30-day readmission were hypertension, CLI, diabetes, renal failure, dyslipidemia, smoking, chronic pulmonary disease, and atrial fibrillation (p < .005). Length-of-stay was greater than 5 days for 56.2 and 75.4% paid by Medicare.
CONCLUSIONS: Our study shows an average yearly readmission rate of 21.5% post-PVI. Chronic comorbidities, prolonged hospitalization was associated with higher risk of 30-day readmission.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  hospital readmission; peripheral arterial disease; peripheral vascular interventions

Year:  2021        PMID: 33860990     DOI: 10.1002/ccd.29698

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  1 in total

1.  Effect of Peptidylarginine Deiminase 4 on Endothelial Progenitor Cell Function in Peripheral Arterial Disease.

Authors:  Jialin Pan; Wenqin Liu; Ye Chen; Chi Zhang; Cong Lin
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-26       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.